Marothi LETSOALO

Photo of Marothi Letsoalo

Marothi LETSOALO

Biostatistics | Epidemiology | Translational Analytics

Welcome

I am a biostatistician and data scientist with over 7 years of experience in clinical trials, cohort studies, and public health analytics.

I work at the intersection of biostatistics, epidemiology, and translational analytics, leading current analyses in CO-LUMINATE to quantify how childhood social determinants of health drive developmental cascades toward adolescent depression through longitudinal phenotype modeling and causal mediation, while advancing PhDDesk for precision maternal epidemiology in obstetric HIV; in parallel, I am building ProtoSynth, a simulation-first, privacy-by-design generative AI platform that grounds analysis logic in protocol documents and enables robust, auditable R/Python pipelines from synthetic data before real-world deployment, and developing PULSE (Project Unit Logistics & Statistics Engine), a multi-tenant biostatistics and data-management operations platform for standardized project structure, granular deliverable tracking, adaptive protocol representation, and full-lifecycle research governance from design to publication.

Publication Track Record

flowchart LR
  S([Publication Track Record]) --> Y2021["2021<br/>(1 output)"]
  Y2021 --> F2021S["Biostatistics &<br/>Reproductive Health (1)"]

  Y2021 --> Y2022["2022<br/>(2 outputs)"]
  Y2022 --> F2022T["TB & Infectious<br/>Disease (1)"]
  Y2022 --> F2022M["Mental Health &<br/>Pharmacy (1)"]

  Y2022 --> Y2023["2023<br/>(8 outputs)"]
  Y2023 --> F2023H["HIV/TB Clinical<br/>Research (6)"]
  Y2023 --> F2023I["Immunology &<br/>Vaginal Health (1)"]
  Y2023 --> F2023P["Vaccine/Pharmacy<br/>Policy (1)"]

  Y2023 --> Y2024["2024<br/>(5 outputs)"]
  Y2024 --> F2024T["DR-TB Diagnostics &<br/>Program Studies (1)"]
  Y2024 --> F2024I["Genital Immunology &<br/>Microbiology (2)"]
  Y2024 --> F2024R["Pharmacology &<br/>Intervention Studies (2)"]

  Y2024 --> Y2025["2025<br/>(4 outputs)"]
  Y2025 --> F2025H["HIV Prevention &<br/>Microbiome (2)"]
  Y2025 --> F2025T["HIV-TB PK and<br/>Co-treatment (2)"]

  Y2025 --> Y2026["2026<br/>(1 output)"]
  Y2026 --> F2026C["HIV/TB Phase 2b<br/>Trial Outcomes (1)"]

  linkStyle default stroke-width:2.4px;

  classDef year fill:#1f3b63,color:#ffffff,stroke:#142a46,stroke-width:1px;
  classDef stats fill:#90be6d,color:#12310f,stroke:#6ea84d,stroke-width:1px;
  classDef hivtb fill:#0f766e,color:#ffffff,stroke:#0a5f58,stroke-width:1px;
  classDef immun fill:#2a9d8f,color:#ffffff,stroke:#1f7f74,stroke-width:1px;
  classDef mental fill:#8ecae6,color:#102a43,stroke:#5ea4c9,stroke-width:1px;
  classDef policy fill:#f4a261,color:#1f2d3d,stroke:#d9822b,stroke-width:1px;
  classDef pharm fill:#457b9d,color:#ffffff,stroke:#2f5f7b,stroke-width:1px;

  class Y2021,Y2022,Y2023,Y2024,Y2025,Y2026 year;
  class F2021S stats;
  class F2022T,F2023H,F2024T,F2025T,F2025H,F2026C hivtb;
  class F2023I,F2024I immun;
  class F2022M mental;
  class F2023P policy;
  class F2024R pharm;

Based on ORCID-synced works (n = 21) updated on 02 March 2026.